Thymosin Alpha-1
Also known as: Zadaxin, Thymalfasin, TA1
A naturally occurring peptide first isolated from the thymus gland that plays a key role in immune regulation. The branded version (Zadaxin) is approved in over 35 countries for hepatitis and immune support, but compounding was restricted in the US until an expected 2026 reclassification.
How it works
Thymosin Alpha-1 works by stimulating the maturation of T-cells from stem cells in the thymus gland. It boosts the activity of natural killer cells, dendritic cells, and macrophages. It also increases the production of cytokines like interleukin-2 and interferon-alpha, which coordinate the immune response. Think of it as a training signal for your immune system's front-line defenders.
Common uses
- Immune system support and modulation
- Chronic hepatitis B and C (international use)
- Cancer adjunct therapy (international use)
- Chronic infection support
- Vaccine response enhancement in elderly patients
Side effects
- Generally well-tolerated in clinical use worldwide
- Injection site redness or discomfort
- Mild flu-like symptoms in some patients
- Rare reports of skin rash
- Fatigue during initial treatment period
Key research
- Approved in 35+ countries based on clinical trials for hepatitis B and C
- COVID-19 clinical trial (NCT04487444) evaluated Thymosin Alpha-1 for immune modulation in critically ill patients
- Multiple trials show improved vaccine response in elderly and immunocompromised patients
- Studies in cancer patients show improved immune markers when used alongside chemotherapy
Safety notes
- Was placed on FDA Category 2 (do not compound) list in 2023, which was the most controversial Category 2 decision
- Expected to return to Category 1 under the 2026 reclassification, but no formal rule change has been published yet
- The FDA restriction was based on lack of US NDA, not on safety or efficacy concerns
- Quality of compounded product depends heavily on the pharmacy
Too many clinics, not enough clarity?
We don't sell peptides. Tell us your goals and we'll connect you with a vetted provider who can figure out what actually makes sense for you.
See what's right for youExplore other peptides
Semaglutide
An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management. One of the most well-studied peptides available.
Tirzepatide
A dual GIP/GLP-1 receptor agonist that has shown even greater weight loss results than semaglutide in head-to-head trials.
BPC-157
A synthetic peptide derived from human gastric juice, studied primarily in animal models for its regenerative and anti-inflammatory properties. Not FDA-approved.
CJC-1295 / Ipamorelin
A commonly paired combination of growth hormone-releasing peptides used to stimulate natural GH production for anti-aging, body composition, and recovery.